Philips has unveiled Azurion, the company's next-generation image-guided therapy platform, capable of performing a wide range of routine, as well as minimally-invasive, catheter-based procedures in the interventional lab or hybrid operating room (OR).
GE Ventures and Northwell Health's Feinstein Institute for Medical Research (FIMR) have entered into a "strategic alliance" to co-develop bioelectronic devices for the treatment of nervous system-mediated acute and chronic diseases.
Using fiber optics, University of Central Florida (UCF) researchers have developed a technique to monitor, in real time, the formation of dangerous blood clots during cardiovascular procedures.
In an effort to curtail runaway medical device prices, Indian government regulators could soon expand price control from cardiac stents to cover 14 other types of device.
A bipartisan bill filed by Sens. Johnny Isakson (R-Ga.) and Michael Bennet (D-Colo.) is seeking to make U.S. Food and Drug Administration (FDA) inspections of medical device facilities in the United States and abroad much quicker, more uniform, and more efficient.
Medtronic's newest addition to its growing minimally-invasive surgery portfolio is the single-handed, powered Signia surgical stapler, which has the ability to sense human tissue thickness and automatically adjust stapling speed to achieve consistent staple lines.
Integra LifeSciences has agreed to purchase Johnson & Johnson (J&J) subsidiary Codman Neurosurgery for $1.05 billion, with plans to build a more comprehensive neurosurgery portfolio and expand its international foothold.
The number of patients under remote monitoring using interconnected devices jumped by 44 percent to 7.1 million in 2016, as patients and providers continue to realize the convenience and cost-efficiency of mHealth devices and applications, according to a report by Berg Insight.
Allergan is buying Zeltiq Aesthetics and its CoolSculpting fat reduction technology in a $2.475 billion, all-cash transaction that’s expected to close in the second half of 2017. The acquisition strengthens Allergan's prospects in the $4 billion body contouring global market.
Wearables company Jawbone reportedly is planning to shift from selling fitness trackers geared towards consumers to developing medical-grade devices and accompanying software services.